Differential Modulation of the DR5–JNK–PD-L1 Signaling Axis by TRiC/CCT Subunits CCT7 and CCT2 Shapes Tumor Immune Evasion in Lung Adenocarcinoma
Cells · 2026
DOI: 10.3390/cells15171613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Hsin-Wei Jen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Center, Department of Research, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan. Hauptthemen laut MEDLINE: Chaperonin Containing TCP-1, Adenocarcinoma of Lung, B7-H1 Antigen, Lung Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
While the chaperonin-containing TCP-1 (CCT) complex is essential for proteostasis, the distinct roles of individual subunits in tumor immune regulation remain unclear. Here, we identify CCT7 as a previously unrecognized regulator of immune evasion in lung adenocarcinoma (LUAD). Integrative analyses of TCGA and GEO cohorts revealed that CCT7 is markedly upregulated in LUAD and is associated with poor patient prognosis. Functional studies demonstrated that CCT7 knockdown inhibited tumor cell proliferation and migration and enhanced cisplatin-induced apoptosis, yet paradoxically impaired T-cell activation. Mechanistically, transcriptomic and biochemical analyses revealed that CCT7 depletion activated the DR5–MKK4–JNK–c-Jun signaling cascade, resulting in the transcriptional upregulation of PD-L1. Disruption of DR5 or JNK signaling effectively abrogated PD-L1 induction. In contrast, CCT2 depletion exerted the opposite effect by suppressing the DR5–JNK–c-Jun–PD-L1 signaling axis and enhancing T-cell activation. Collectively, these findings reveal unexpected functional divergence among TRiC/CCT subunits and identify the CCT7–DR5–JNK–c-Jun signaling axis as a previously unrecognized mechanism regulating PD-L1-mediated immune evasion, highlighting the potential therapeutic relevance of this signaling axis in LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Medicine Center, Department of Research, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan.
- Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan.
- Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
- Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Förderung
- National Science and Technology Council
Zitieren
APA
Jen, H. W., Ho, H. L., & Chou, T. Y. (2026). Differential Modulation of the DR5–JNK–PD-L1 Signaling Axis by TRiC/CCT Subunits CCT7 and CCT2 Shapes Tumor Immune Evasion in Lung Adenocarcinoma. Cells. https://doi.org/10.3390/cells15171613
Vancouver
Jen HW, Ho HL, Chou TY. Differential Modulation of the DR5–JNK–PD-L1 Signaling Axis by TRiC/CCT Subunits CCT7 and CCT2 Shapes Tumor Immune Evasion in Lung Adenocarcinoma. Cells. 2026. doi:10.3390/cells15171613
BibTeX
@article{Jen2026,
author = {Jen, Hsin-Wei and Ho, Hsiang-Ling and Chou, Teh-Ying},
title = {Differential Modulation of the DR5–JNK–PD-L1 Signaling Axis by TRiC/CCT Subunits CCT7 and CCT2 Shapes Tumor Immune Evasion in Lung Adenocarcinoma},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15171613}
}
EUVIMED